BMRN vs BRBS · P/E 40, rev $1.76B vs rev $58.2M
Biomarin Pharmaceutical Inc (BMRN) versus Blue Ridge Bankshares Inc (BRBS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Blue Ridge Bankshares Inc (BRBS) is a banks - regional company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported BRBS revenue for 2026-06-30 was $58.2M. Net income was -$459.0K. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. BRBS currently screens at market cap $328.2M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. BRBS currently screens at market cap $328.2M.
Not investment advice. Open the BMRN and BRBS stock pages for the full models.
Not investment advice.